Quantbot Technologies LP I Mab Transaction History

Quantbot Technologies LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$3.22 - $4.86 $13,346 - $20,144	4,145 New	4,145 $17,000
Q3 2021 Nov 09, 2021	SELL	$57.18 - $84.43 $102,924 - $151,974	-1,800 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$47.86 - $83.95 $86,148 - $151,110	1,800 New	1,800 $151,000

16M

11.9K

3.5K

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $131M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.